Radioiodine therapy temporarily increases circulating endothelial cells and decreases circulating endothelial progenitor cells

Nuclear Medicine Review

Volumn 6, Issue 2, 2003, Pages 123-126

  Palumbo, Barbara ^a   Palumbo, Renato ^a   Sinzinger, Helmut ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b Wilhelm Auerswald Atherosclerosis Research Group   (Austria)

Author keywords

Circulating endothelial cells; Radiation injury; Radioiodine therapy; Thyroid cancer

Indexed keywords

IODINE 131; LIPOPROTEIN; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; BLOOD VESSEL INJURY; BLOOD VESSEL WALL; CANCER RADIOTHERAPY; CELL COUNT; CELL KINETICS; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DESQUAMATION; DIABETES MELLITUS; DOSE RESPONSE; ENDOTHELIUM CELL; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HYPERLIPOPROTEINEMIA; HYPERTENSION; MEDICAL ASSESSMENT; RADIATION INJURY; RISK FACTOR; STEM CELL; THYROID CANCER; TREATMENT OUTCOME; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HYPERTHYROIDISM; RADIATION EXPOSURE; RADIATION RESPONSE; THYROID TUMOR; VASCULAR DISEASE;

DOSE-RESPONSE RELATIONSHIP, RADIATION; ENDOTHELIAL CELLS; HUMANS; HYPERTHYROIDISM; IODINE RADIOISOTOPES; RADIATION INJURIES; RADIOPHARMACEUTICALS; STEM CELLS; THYROID NEOPLASMS; VASCULAR DISEASES;

EID: 3042739360     PISSN: 15069680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Van Nostrand D, Neutze J, Atkins F. Side effects of "rational dose" iodine-131 therapy for metastatic well-differentiated thyroid carcinoma. J Nucl Med 1986; 27: 1519-1527.
2. Wichers M, Benz E, Palmedo H, Biersack HJ, Grünwald F, Klingmüller D. Testicular function after radioiodine therapy for thyroid carcinoma. Eur J Nucl Med 2000; 27: 503-507.
3. Resch U, Weiss K, Tatzber F, Sinzinger H. Influence of radioiodine therapy on in-vivo lipoprotein oxidation. Nucl Med Commun 1999; 20: 949-950.
4. Wolfram R, Palumbo B, Chehne F, Palumbo R, Sinzinger H. (Iso) Prostaglandins in saliva indicate oxidation injury after radioiodine therapy. Rev Esp Nucl Med 2003 (submitted).
5. 2α. J Nucl Med 2002; 43: 1254-1258.
6. 2 and circulating endothelial-cells in peripheral vascular disease. Angiology 1986; 37: 112-118.
7. George F, Brisson P, Poncelet P, Laurent JC, Masot O, Arnoux D, Ambrosi P, Klein-Soyer C, Cazenave JP, Sampol R. Rapid isolation of human endothelial cells from whole blood using S-Endo 1 monoclonal antibody coupled with immunomagnetic beads: demonstration of endothelial injury after angioplasty. Thromb Haemost 1992; 67: 147-153.
8. Hladovec J. Circulating endothelial cells as a sign of vessel wall lesions. Physiologia Bohemoslav 1978; 27: 140-144.
9. Najemnik C, Sinzinger H, Kritz H. Endothelial dysfunction, atherosclerosis and diabetes. Acta Med Austr 1999; 26: 148-153.
10. Davis JW, Shelton L, Eigenberg DA, Hignite CE, Watanabe IS. Comparison of tobacco and non-tobacco cigarette smoking on endothelium and platelets. Clin Pharmacol Ther 1985; 37: 529-533.
11. Davis JW, Shelton L, Eigenberg DA, Hignite CE. Lack of effect of aspirin on cigarette smoke-induced increase in circulating endothelial cells. Haemostasis 1987; 7: 66-69.
12. Sinzinger H, Rauscha F, Fitscha P, Kaliman J. Effect of high and low-dose aspirin on circulating endothelial cells. VASA 1988; 17: 84-88.
13. Mutin M, Canavy I, Blann A, Bory M, Sampol J, Dignat-George F. Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells. Blood 1999; 93: 2951-2958.
14. 2 on circulating endothelial cells. Basis Res Cardiol 1988; 83: 597-601.
15. Camoin-Hau L, Kone-Paut I, Chabrol B, Sampol J, Dignat-George F. Circulating endothelial cells in Behcet's disease with cerebral thrombophlebitis. Thromb Haemost 2000; 83; 631-632.
16. George F, Brouqui P, Boffa MC, Mutin M, Drancourt M, Brisson C, Raoult D, Sampol J. Demonstration of Rickettsia conorii induced endothelial injury in vivo by measuring circulating endothelial cells, thrombomodulin and von Willebrand factor in patients with Mediterranean spotted fever. Blood 1993; 82: 2109-2116.
17. Lefévre P, George F, Durand JM, Sampol J. Detection of circulating endothelial cells in thrombotic thrombocytopenic purpura. Thromb Haemost 1993; 69: 522.
18. Schmitz-Huebner U, Knob J. Evidence for an endothelial cell dysfunction in association with Behcet's disease. Thromb Res 1982; 34: 277-285.
19. Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells. Science 1997; 275: 964-967.
20. Asahara T, Masuda H, Takahashi et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999: 85: 221-228.
21. Vasa M, Fichtlscherer S, Aicher A et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001; 89: E1-E7.
22. Hill JM, Zalos G, Halcox JPJ et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risks. New Engl J Med 2003; 348: 593-600.
23. Vasa M, Fichtlscherer S, Adler K et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001; 103: 2885-2890.